Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Metabolic signals and cell shape influence how cells develop and change.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Desmoglein 4 is controlled by specific proteins that affect hair growth.

Different types of polycystic ovary syndrome show varying levels of insulin resistance, with the 'PHO' type being the most insulin resistant.

Removing a hormone-producing adrenal tumor can stop hair loss in women with high testosterone levels.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

CDP is crucial for lung and hair follicle cell development.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

Harlequin mutant mice have hair loss due to low AIF protein levels and retroviral element activity.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Immune cells are essential for early hair and skin development and healing.

Early-stage Alopecia Areata was effectively treated in less than six months.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.